CompletedPhase 3NCT00566332

Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström Macroglobulinemia

Studying Waldenström Macroglobulinemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
French Study Group on Chronic Lymphoid Leukemia
Principal Investigator
Véronique LEBLOND, Professor
French Study Group on Chronic Lymphoid Leukemia
Intervention
Chlorambucil(drug)
Enrollment
414 enrolled
Eligibility
18 years · All sexes
Timeline
2001 – 2014

Study locations (1)

Collaborators

Lymphoma Study Association · French Innovative Leukemia Organisation · Département de Biostatistiques et Informatique Médicale DBIM

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00566332 on ClinicalTrials.gov

Other trials for Waldenström Macroglobulinemia

Additional recruiting or active studies for the same condition.

See all trials for Waldenström Macroglobulinemia →

← Back to all trials